161O Randomized preoperative window of opportunity (WOO) study with the CDK4/6 inhibitor abemaciclib in early breast cancer (EBC) patients and differential gene expression pathway analyses with palbociclib

Autor:	Ingrid Garberis, I. Bouakka, Stefan Michiels, David Gentien, Magali Lacroix-Triki, Monica Arnedos, Fabrice Andre, D. Chaltiel, A.A. Viansone, Françoise Rimareix, Julien Adam, Véronique Scott, Nicolas Leymarie, Damien Drubay, A. Vieillefon, Bianca Cheaib
Rok vydání:	2020
Předmět:	Oncology Window of opportunity medicine.medical_specialty business.industry Hematology Palbociclib chemistry.chemical_compound chemistry Internal medicine Gene expression medicine business Abemaciclib Early breast cancer
Zdroj:	Annals of Oncology. 31:S304
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::82c82d40a4958b6ed0afdcf5e4db91a4 https://doi.org/10.1016/j.annonc.2020.08.283 Zobrazit plný text záznamu